Last reviewed · How we verify
Edaravone dexborneol sublingual tablet
Edaravone dexborneol sublingual tablet is a Small molecule drug developed by Simcere Pharmaceutical Co., Ltd. It is currently in Phase 2 development.
At a glance
| Generic name | Edaravone dexborneol sublingual tablet |
|---|---|
| Sponsor | Simcere Pharmaceutical Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study (PHASE4)
- Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease (PHASE3)
- Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients (PHASE2)
- The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Edaravone dexborneol sublingual tablet CI brief — competitive landscape report
- Edaravone dexborneol sublingual tablet updates RSS · CI watch RSS
- Simcere Pharmaceutical Co., Ltd portfolio CI
Frequently asked questions about Edaravone dexborneol sublingual tablet
What is Edaravone dexborneol sublingual tablet?
Edaravone dexborneol sublingual tablet is a Small molecule drug developed by Simcere Pharmaceutical Co., Ltd.
Who makes Edaravone dexborneol sublingual tablet?
Edaravone dexborneol sublingual tablet is developed by Simcere Pharmaceutical Co., Ltd (see full Simcere Pharmaceutical Co., Ltd pipeline at /company/simcere-pharmaceutical-co-ltd).
What development phase is Edaravone dexborneol sublingual tablet in?
Edaravone dexborneol sublingual tablet is in Phase 2.